Ann Mullally

Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social

Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis.
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social

If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!

Very interesting, congrats! 🎊🎉

Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!

Join me @cruk-mi.bsky.social

www.crukcentre.manchester.ac.uk/opportunitie...

For Clinically trained applicants-DM if you have queries

Deadline 17th November 2025

Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social

A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti

Enjoyed this interview!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!

Just add students, a new academic year begins! @stanforduniversity.bsky.social

Scientist, advocate and entrepreneur Lucy Shapiro to receive Lasker-Koshland Special Achievement Award Lucy Shapiro entered biology “like a bolt of lightning.” A groundbreaking scientist, mentor, drug developer and advocate for science communication is recognized for a lifetime of achievements.

Congratulations Lucy Shapiro @stanfordmedicine.bsky.social

med.stanford.edu/news/all-new...

Happening today at noon! 👇🏽

David Baltimore, in his own words (2019).

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽

Congrats, Steven & team - really interesting work!

Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18

Interesting, looking forward to reading this, congrats to all!

Haematopoietic stem cell number is not solely defined by niche availability Nature - Haematopoietic stem cell numbers are restricted at both systemic and local levels.

Please check out this thread on our latest paper in
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)

Platelets sequester and harbor cell-free tumor DNA, which could enhance our ability to make early, microscopic diagnosis of cancer
@science.org

science.org/doi/10.1126/...
science.org/doi/10.1126/...

Rescheduled & happening today at noon! 👇🏽

And here it is! Our study in clonal hematopoiesis and Alzheimer’s disease — product of 5 years’ gestation. urldefense.proofpoint.com/v2/url?u=htt...

Spectacular jacaranda in bloom on campus! @stanforduniversity.bsky.social

Investing in research, education, and care is key to advancing sickle cell and blood disorders worldwide.

The ASH Foundation makes it happen.

Support the cause: https://bit.ly/4hsCh6v

🎥www.youtube.com/watc...

#WorldSickleCellDiseaseDay #Fight4Hematology #SickleCell #HemeSky

Today is #WorldSickleCellDiseaseDay.

Sickle cell disease affects millions, but too many still face delayed diagnosis and limited access to care. Today, ASH raises awareness and invites you to be part of the progress. 🧵👇

Congrats, Ruben! Very well deserved #MPNsm

Congrats to all!

news.abbvie.com/2025-06-16-A... Wow — top line VERONA results are negative — no advantage to AZA + VEN compared to AZA alone for higher-risk #MDSsm. AZA or DAC alone remain the standard for HR-MDS. So disappointing😢 🎗️🩸

Exciting times for mutCALR MPNs - lovely data from the ET cohort presented in late breaking abstract at @EHA_Hematology. Rapid platelet control after just 2 doses with 89% of patients benefitting from a molecular response with INCA033989. @mpnvoice.bsky.social @mpnrf.bsky.social @mpnhv.bsky.social

Immunotherapy cured her mother’s cancer, then drew her into medicine When Gita Abhiraman was a child, an early form of immunotherapy saved her mother’s life. She has dedicated her career to finding innovative treatments that could help others.

Gita Abhiraman, who is graduating from the Stanford School of Medicine, was inspired to pursue a career in immunotherapy after an early treatment saved her mother’s life. Now, she’s focused on advancing treatments that improve patient outcomes. stan.md/3G1zTXo

#StanfordMed2025

Congratulations, Quinn!
Keep doing great science!